Login

Pharmaceutical Giant Bayer Puts St. Louis Campus on the Market for Potential Redevelopment

Former Monsanto Headquarters Site in Creve Coeur Could Accommodate More Than 2 Million Square Feet
Bayer's Creve Coeur campus is being marketed for immediate occupancy or for a full redevelopment. (CoStar)
Bayer's Creve Coeur campus is being marketed for immediate occupancy or for a full redevelopment. (CoStar)
By Matthew Reyna
CoStar Research
March 15, 2022 | 6:56 P.M.

Bayer has put its St. Louis campus up for sale in a potential deal that could set up one of the larger redevelopments in the area.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE